Artificial Intelligence | Machine Learning Scailyte | Precision Medicine Through Single-Cell Science


Enterprise, Biotechnology, Managed Healthcare, Health Diagnostics, Pharmaceuticals Basel, Basel-Stadt, Switzerland

Scailyte

Artificial Intelligence | Machine Learning


Scailyte | Precision Medicine Through Single-Cell Science

Scailyte

Biotechnology, Managed Healthcare, Health Diagnostics, Pharmaceuticals


Basel, Basel-Stadt, Switzerland

Scailyte develops artificial intelligence technology for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into diseases by uncovering human's hidden "single-cell"? secrets. Our AI-based software ScaiVision offers best-in-class performance for supervised pattern recognition analysis of single-cell data. The performance and clinically-relevant application of the deep learning algorithm have been demonstrated in a scientific publication by our co-founder Prof. Claassen (ETH Zurich). ScaiVision will allow our customers to reduce data analysis time and costs, while increasing groundbreaking insights.

Moreover, we are also providing biomarker discovery services leveraging our expertise in single-cell technologies and our AI-based data analytics solutions. We support pharmaceutical companies during the drug discovery & development process by introducing and implementing single-cell approaches for the discovery of novel disease mechanisms, as well as the discovery of biomarkers for drug efficacy, toxicity, and patient stratification. Our AI platform, ScaiVision, combines features to integrate different datasets, is indication- and cell-type agnostic and uses data augmentation and a cluster-free approach to extract relevant information while retaining single-cell resolution. These features result in very high discovery success rates from a limited number of samples, with actionable insights for the basis of assay development.

 

B2B

1 to 25

Series A

$6,889,835

Scaling Up

2017

 
 

Pharmaceuticals
Healthcare
Biotechnology

Optimize Product Manufacturing
Improve Clinical Outcomes

Increase Efficiency

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning


Diagnostic Developments

Diagnostic Developments

Biomedical Insights

Biomedical Insights

Precision Diagnostic Portfolio

Precision Diagnostic Portfolio


Image

Image

Text

Text

Time Series

Time Series

 

   Software


Tensorflow

Tensorflow

Flink

Flink

Kubernetes

Kubernetes

Docker

Docker

Java

Java

C/C++

C/C++

Python

Python

Azure SQL

Azure SQL


Machine Learning Algorithm

Machine Learning Algorithm

Sensitive Algorithms

Sensitive Algorithms

Deep Learning Algorithm

Deep Learning Algorithm

 
 

2

1

$6.1M

Company was founded 2017 and it took almost 5 years (Sep 2022) to raise first external round

 
 

Date

Round

$ Raised

Investors

09/22/2022

Series A

$6.1M

Mirabaud, Swisscom Ventures

Date : 09/22/2022

Round: Series A

$ Raised: $6.1M

Investors: Mirabaud, Swisscom Ventures

 

Investors

Interested in researching Scailyte?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Scailyte

Request a Demo - Deal Souring Platform

 
Peter Nestorov


Peter Nestorov
Founder & CEO

Dennis Göhlsdorf


Dennis Göhlsdorf
CTO

Corinne Solier

Corinne Solier
Chief Operating Officer

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Scailyte